Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 10933015 Injectable composition with aromatase inhibitor

Patent 10933015 was granted and assigned to Laboratorios Farmaceuticos Rovi on March, 2021 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

Laboratorios Farmaceuticos Rovi

0

Current Assignee

Laboratorios Farmaceuticos Rovi

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Guillermo Franco Rodriguez0

Ibon Gutierro Aduriz0

Date of Patent

March 2, 2021

0

Patent Application Number

162940520

Date Filed

March 6, 2019

0

Patent Citations

US Patent 10182982 Antipsychotic injectable depot composition

US Patent 10058504 Methods for the preparation of injectable depot compositions

US Patent 10085936 Antipsychotic injectable depot composition

US Patent 10195138 Methods for the preparation of injectable depot compositions

Patent Citations Received

US Patent 11918682 Injectable composition with aromatase inhibitor

0

Patent Primary Examiner

Katherine Peebles

0

Patent abstract

The present invention provides a composition suitable for forming an intramuscular implant. It comprises a biodegradable thermoplastic polymer of polylactic acid (PLA), DMSO and an aromatase inhibitor compound. The invention also provides a kit suitable for the in situ formation of the composition and its use as a medicine for treating cancer, especially breast cancer.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10933015 Injectable composition with aromatase inhibitor

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool